Fidelity International reduced its holdings of Joinn Laboratories (06127) by 1.6108 million shares, with an average price of approximately HKD 21.57 per share.
On September 16th, Fidelity International reduced its holding of China Medical System (06127) by 1.6108 million shares, with an average price per share of HK$21.5742, totaling approximately HK$34.7517 million.
According to the latest data from the Hong Kong Stock Exchange, on September 16, Fidelity International reduced its holdings of Joinn Laboratories (06127) by 1.6108 million shares, with an average price of 21.5742 Hong Kong dollars per share, totaling approximately 34.7517 million Hong Kong dollars. The latest number of shares held after the reduction is 11.4548 million shares, with a latest shareholding percentage of 9.63%.
This transaction involves other related parties: Pandanus Associates Inc., Pandanus Partners L.P.
Related Articles

New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


